1. Home
  2. CFLT vs ABVX Comparison

CFLT vs ABVX Comparison

Compare CFLT & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CFLT
  • ABVX
  • Stock Information
  • Founded
  • CFLT 2014
  • ABVX 2013
  • Country
  • CFLT United States
  • ABVX France
  • Employees
  • CFLT N/A
  • ABVX N/A
  • Industry
  • CFLT EDP Services
  • ABVX
  • Sector
  • CFLT Technology
  • ABVX
  • Exchange
  • CFLT Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • CFLT 5.9B
  • ABVX 5.3B
  • IPO Year
  • CFLT 2021
  • ABVX N/A
  • Fundamental
  • Price
  • CFLT $19.24
  • ABVX $84.01
  • Analyst Decision
  • CFLT Buy
  • ABVX Strong Buy
  • Analyst Count
  • CFLT 30
  • ABVX 8
  • Target Price
  • CFLT $29.13
  • ABVX $90.63
  • AVG Volume (30 Days)
  • CFLT 7.9M
  • ABVX 1.2M
  • Earning Date
  • CFLT 10-29-2025
  • ABVX 08-11-2025
  • Dividend Yield
  • CFLT N/A
  • ABVX N/A
  • EPS Growth
  • CFLT N/A
  • ABVX N/A
  • EPS
  • CFLT N/A
  • ABVX N/A
  • Revenue
  • CFLT $1,064,824,000.00
  • ABVX $7,073,400.00
  • Revenue This Year
  • CFLT $21.83
  • ABVX $25.23
  • Revenue Next Year
  • CFLT $16.44
  • ABVX N/A
  • P/E Ratio
  • CFLT N/A
  • ABVX N/A
  • Revenue Growth
  • CFLT 23.02
  • ABVX N/A
  • 52 Week Low
  • CFLT $15.64
  • ABVX $4.77
  • 52 Week High
  • CFLT $37.90
  • ABVX $92.91
  • Technical
  • Relative Strength Index (RSI)
  • CFLT 48.41
  • ABVX 67.94
  • Support Level
  • CFLT $18.34
  • ABVX $82.72
  • Resistance Level
  • CFLT $20.62
  • ABVX $91.30
  • Average True Range (ATR)
  • CFLT 0.75
  • ABVX 3.62
  • MACD
  • CFLT 0.28
  • ABVX -1.13
  • Stochastic Oscillator
  • CFLT 56.90
  • ABVX 47.89

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: